Carisoprodol Efficacy and Safety Compared to Other Muscle Relaxants

Evidence of Comparative Efficacy

The American College of Physicians suggests that carisoprodol demonstrated superiority over diazepam for muscle spasm, functional status, and global efficacy in head-to-head trials for acute low back pain, with 70% vs. 45% rated "excellent" or "very good" 1
The American College of Physicians found no evidence that carisoprodol is more effective than non-benzodiazepine muscle relaxants such as cyclobenzaprine, methocarbamol, or metaxalone 2, 1
A pooled analysis of 20 trials found no difference between diazepam and cyclobenzaprine for short-term global improvement in back pain, suggesting muscle relaxants as a class have similar efficacy profiles 1
Systematic reviews conclude that muscle relaxants are effective for short-term symptomatic relief but show no clear superiority of one agent over another, according to the American Academy of Family Physicians 2, 3

The FDA classifies carisoprodol as a controlled substance due to escalating abuse and addiction potential, making it one of the most commonly diverted drugs in the United States 4, 5
Carisoprodol has "substantial barbiturate-like biological action" and is a CNS depressant with anxiolytic properties, contributing to its abuse liability, as reported by the National Institute on Drug Abuse 4
Carisoprodol causes numerous adverse effects including sedation, seizures, drug dependence, withdrawal, tachycardia, and postural hypotension, according to the Mayo Clinic 4
Withdrawal symptoms can be severe and include insomnia, vomiting, tremors, muscle twitching, anxiety, ataxia, and potentially hallucinations and delusions 4, 5

The Society for Perioperative Assessment and Quality Improvement recommends holding carisoprodol on the day of operation, and if time permits, tapering off or switching to an alternative agent before surgical procedures 4, 5
The American Geriatrics Society recommends baclofen as the preferred agent for elderly patients requiring muscle relaxant therapy, starting at 5 mg three times daily with gradual titration 6
Tizanidine is another recommended option with emerging evidence for perioperative benefit, including improved postoperative pain control and decreased opioid consumption, according to the American Society of Anesthesiologists 5, 6

Muscle relaxants as a class are effective for short-term (up to 2-3 weeks) symptomatic relief in acute musculoskeletal conditions, as stated by the American Academy of Orthopaedic Surgeons 2, 3
NSAIDs are equally effective as muscle relaxants for acute low back pain and have fewer adverse effects than muscle relaxants or opioids, according to the American College of Rheumatology 3
Non-benzodiazepine muscle relaxants (excluding carisoprodol) are more effective than placebo for short-term pain relief and global efficacy in acute low back pain, as reported by the Cochrane Review 3
Choose cyclobenzaprine, methocarbamol, or metaxalone over carisoprodol for acute musculoskeletal conditions requiring muscle relaxation, as these agents have similar efficacy without the controlled substance classification, according to the American Academy of Family Physicians 2, 1
Consider NSAIDs or acetaminophen as first-line therapy before any muscle relaxant, given comparable efficacy and superior safety profiles, as recommended by the American Academy of Pediatrics 3, 7